Advertisement
A novel rifabutin-based triple therapy is effective for eradication of Helicobacter pylori

RHB-105 Effective for Eradication of Helicobacter pylori in Adults

0
Eradication rates with triple therapy unaffected by resistance to clarithromycin, metronidazole
For patients hospitalized with COVID-19

Anticoagulation May Improve Outcomes in COVID-19 Patients

0
Longer duration of AC treatment linked to reduced risk for mortality in hospitalized patients
Gastrointestinal symptoms are seen in less than 10 percent of patients with COVID-19

GI Symptoms Seen in Less Than 10 Percent of COVID-19 Patients

0
Outpatients with new-onset GI symptoms should be monitored for COVID-19 symptoms
Human trials on an experimental COVID-19 vaccine began in the United States on Monday

Human Trials of Experimental COVID-19 Vaccine Begin in U.S.

0
If effective, vaccine could be available for emergency use in the United States as early as September
Health care workers and younger people have an increased risk for a psychological impact from COVID-19

Health Care Workers at Risk From Mental Burden of COVID-19

0
Prevalence of anxiety symptoms higher for health care workers/young spending more time on outbreak
A prototype for a low-cost

Low-Cost, Noninvasive Ventilator Feasible for Breathing Support

0
Inspiratory/expiratory pressures up to 20/10 cmH20, respectively; no faulty triggering, cycling
In a CHEST expert panel report

Guidance Developed for Lung Cancer Screening During COVID-19

0
Consensus statement covers lung cancer screening and monitoring, evaluation, management of lung nodules
Many sexually active men who have sex with men do not receive recommended prevention services and sexually transmitted disease testing when receiving care for HIV infection

HIV+ Men Are Not Receiving STD Testing, Prevention Services

0
Men receiving HIV care still not receiving guideline-recommended sexually transmitted disease testing
Age and underlying cardiovascular disease are associated with in-hospital mortality in COVID-19

ACE Inhibitors, ARBs Not Linked to In-Hospital COVID-19 Death

0
Risk for in-hospital death increased with age >65, underlying cardiovascular disease, COPD, smoking
In an evidence-based guideline developed by an international team of physicians

Guideline Issued for Nonsevere, Severe COVID-19 Therapy

0
Corticosteroids recommended for severe COVID-19 with ARDS but not severe COVID-19 without ARDS